When standard PTSD meds fall short, one unlikely combination quietly delivers stronger, broader symptom relief.

Most smokers relapse—but a clever second-round strategy might finally tip the odds in their favor.

A massive meta-analysis of over one million participants provides the most comprehensive real-world comparison to date of methadone versus buprenorphine for opioid use disorder. While both medications are effective, methadone shows superior treatment retention at 3, 6, and 12 months, though the medications are largely comparable in other outcomes.

The first randomized controlled trial testing varenicline for e-cigarette cessation shows encouraging results. With 45% of participants achieving 7-day abstinence at week eight compared to 30% on placebo, this study provides preliminary evidence that varenicline may be effective for helping patients quit vaping, expanding its utility beyond traditional tobacco cessation.

A new plasma test, eMTBR-tau243, could revolutionize Alzheimer’s diagnosis by detecting tau tangles with precision and offering a faster, less invasive window into disease progression.

A new digital tool helps clinicians compare psychiatric medications based on side effect profiles—streamlining complex decisions with data from dozens of major studies and treatment guidelines.

Researchers compares treatments for antipsychotic-induced akathisia, highlighting options that may offer relief with fewer side effects.